Sanofi
SNY
40.20
+0.64
+1.62%
Sanofi
US · SNY
#211 by market cap
Listed 1970
40.20
+0.64
+1.62%
Live - 5344 symbols - heartbeat 289s ago
· 2026-10-08 07:37
Pre-market
39.91
-0.72%
After-hours
40.20
0.00%
Overnight
39.95
-0.62%
- Market cap
- 96.32B
- P/E (TTM)i
- 21.97
- P/Bi
- 1.24
- EPSi
- 3.57
- Div yieldi
- 5.88%
- 52W posi
- 10%
Reader sentiment
Are you bullish or bearish on SNY?
Anonymous reader poll. Unscientific, not investment advice.
Analyst consensus 3 analysts
Hold
Avg price target
53.00 +31.8%
Price target rangecurrent 40.20
Low49.00
Avg53.00
High57.00
Buy 0%
Hold 100%
Sell 0%
Recent ratings (14)
| Date | Firm | Analyst | Rating | Target |
|---|---|---|---|---|
| 2026-08-31 | TD Cowen | -- | HOLD | 57.00 |
| 2026-07-09 | Guggenheim | -- | HOLD | -- |
| 2026-07-08 | Morgan Stanley | -- | HOLD | 49.00 |
| 2026-06-29 | TD Cowen | -- | HOLD | 57.00 |
| 2026-05-01 | Morgan Stanley | -- | HOLD | 52.00 |
| 2026-04-23 | TD Cowen | -- | HOLD | 57.00 |
| 2026-04-08 | TD Cowen | -- | HOLD | 57.00 |
| 2026-03-31 | TD Cowen | -- | HOLD | 57.00 |
| 2026-02-19 | TD Cowen | -- | HOLD | 57.00 |
| 2026-01-06 | Barclays | -- | HOLD | -- |
| 2025-12-30 | TD Cowen | -- | HOLD | 57.00 |
| 2025-12-17 | TD Cowen | -- | HOLD | 57.00 |
| 2025-12-09 | Guggenheim | -- | HOLD | -- |
| 2025-12-02 | HSBC | -- | BUY | 118.17 |
Quant vs Street three independent views, side by side
StockVane factor grade
C
Momentum strategy signal
Sell
Analyst consensus
Hold
Mostly aligned, one view stands apart.
Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.
Price target trend monthly average, last 3 years
Earnings history price reaction on the day
| Period | Report date | Session | Options expected | Actual move |
|---|---|---|---|---|
| 2026/Q3 | 2026-10-30 | -- | -- | -- |
| 2026/Q2 | 2026-07-30 | -- | ±4.17% | -4.37% (beat) |
| 2026/Q1 | 2026-04-23 | -- | ±6.70% | +1.34% (in line) |
| 2025/Q4 | 2026-01-29 | -- | ±6.84% | +0.94% (in line) |
| 2025/Q3 | 2025-10-24 | -- | ±4.51% | +4.28% (in line) |
| 2025/Q2 | 2025-07-31 | -- | ±5.79% | -7.33% (beat) |
| 2025/Q1 | 2025-04-24 | -- | ±7.99% | +0.98% (in line) |
| 2024/Q4 | 2025-01-30 | -- | ±6.44% | +3.84% (in line) |
| 2024/Q3 | 2024-10-25 | -- | ±6.32% | +4.40% (in line) |
| 2024/Q2 | 2024-07-25 | -- | ±7.77% | +3.71% (in line) |
| 2024/Q1 | 2024-04-25 | -- | ±8.82% | +5.90% (in line) |
| 2023/Q4 | 2024-02-01 | -- | ±7.10% | -2.99% (in line) |
"Options expected" is the pre-earnings options market's implied move (a straddle-style estimate), shown next to what actually happened.
Quote time 2026-10-08 07:37:17 · For reference only, not investment advice and not tailored to your situation.